Epics Therapeutics SA
32.2 FTEEpics Therapeutics reported total assets of €14.7m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026), with 32.2 full-time equivalents.
The score of Epics Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -35 % Total assets -8 % Headcount (avg FTE) +1 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Epics Therapeutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 13 Oct 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 17 Aug 2023
- Year ended 31 Dec 2021filed on 01 Sep 2022
Epics Therapeutics's financial analysis
- Solvency62.0%sector median: 42.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Epics Therapeutics
Epics Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0690.759.071
- VAT number
- BE0690759071
- Peppol
- Registered · 0208:0690759071 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Feb 2018
- Registered office
- 6041 Charleroi
- Size
- Small · 32.2 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Epics Therapeutics (SA) has been based in Charleroi since 2018, active in: manufacture of medicaments. For 2025, it reports a net loss of €5.79m and equity of €9.11m; its revenue is not published. With 32.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 62.0%, above the median of its sector (42.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Epics Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- Aboleris Holdco Research and experimental development on natural sciences and engineering Charleroi · balance sheet €14.8m
- Cellistic Manufacture of pharmaceutical preparations Mont-Saint-Guibert · balance sheet €41.6m
- CellCarta Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €22.4m
- iTeos Belgium Research and experimental development on natural sciences and engineering Charleroi · balance sheet €46.3m
- Univercells Technologies Manufacture of other chemical products n.e.c. Nivelles · balance sheet €16.2m
- Confo Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €37.8m
Frequently asked questions about Epics Therapeutics
What is the revenue of Epics Therapeutics?
Epics Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Epics Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0690759071 for Epics Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0690.759.071.
Where is the registered office of Epics Therapeutics?
According to the CBE register, the registered office of Epics Therapeutics is in 6041 Charleroi.
What is the equity of Epics Therapeutics?
At the close of the 2025 financial year, the equity of Epics Therapeutics amounts to 9,112,305 €, a solvency of 62.0% of total assets.
How many people work at Epics Therapeutics?
32.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Epics Therapeutics?
The register lists 15 active mandates at Epics Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Epics Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →